TMO Free Cash Flow
$7.32BTTM · USD
Period ending:
TMO FY Free Cash FlowUSD
$7.27B-$691.70M
1989-12-312025-12-31
Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.
TMO free cash flow history
Operating cash flow minus capital expenditures. The available annual fiscal periods series contains 37 observations from Dec 31, 1989 to Dec 31, 2025.
| Period ending | Free Cash Flow (USD) |
|---|---|
| 6,293,000,000 | |
| 7,267,000,000 | |
| 6,927,000,000 | |
| 6,911,000,000 | |
| 7,020,000,000 | |
| 6,815,000,000 | |
| 4,047,000,000 | |
| 3,785,000,000 | |
| 3,497,000,000 | |
| 2,711,900,000 | |
| 2,394,000,000 | |
| 2,192,000,000 | |
| 1,728,300,000 | |
| 1,724,400,000 | |
| 1,424,500,000 | |
| 1,232,300,000 | |
| 1,451,700,000 | |
| 1,155,800,000 | |
| 1,308,000,000 | |
| 328,857,000 | |
| 227,368,000 | |
| 214,525,000 | |
| 170,583,000 | |
| 51,680,000 | |
| 103,602,000 | |
| 125,882,000 | |
| -150,879,000 | |
| -72,700,000 | |
| -691,700,000 | |
| 100,000,000 | |
| 131,700,000 | |
| 144,000,000 | |
| 70,100,000 | |
| -5,100,000 | |
| -10,500,000 | |
| -101,400,000 | |
| -300,000 |
Compare free cash flow
Other companies in Healthcare. Each page shows its own reporting periods and currency.
- Lilly (Eli) (LLY) free cash flow
- Johnson & Johnson (JNJ) free cash flow
- AbbVie (ABBV) free cash flow
- UnitedHealth Group (UNH) free cash flow
- Merck & Co. (MRK) free cash flow
- Amgen (AMGN) free cash flow
- Gilead Sciences (GILD) free cash flow
- Abbott Laboratories (ABT) free cash flow
All TMO financial metrics · TMO stock overview · How to interpret financial metrics
